Javascript must be enabled to continue!
Avid Medical, Inc
View through CrossRef
This case describes the rapid growth of a start-up company which benefited from the identification of a specific market niche. The company, over a short time, became positive in EBITDA and then PAT. The case is rich in operational details regarding scheduling, inventories, workforce planning, capacity expansion, and customer service. The strategic issue in the case involves the looming decision to carry the company through its next stage of expansion.
Excerpt
UVA-OM-1021
AVID Medical, INC.
Introduction
It was April 2002 and times were busy for Mike Sahady, the founder and Chief Executive Officer of AVID Medical, Inc. (AVID Medical), and Rick Setian, the Chief Operating Officer. Mike and Rick were busy devising a strategy for AVID Medical to continue into its next stage of growth. AVID had grown from $ 8.8M in revenue in FY2000 to $ 29.5M in revenue for FY2002, and was the fifth largest provider of custom procedure trays (CPTs) in the United States. CPTs were used to bundle all of the disposable supplies required for a single surgical procedure.
The CPT industry presented both challenges and opportunities for AVID. AVID's suppliers and distributors were multi-billion dollar companies, and several of AVID's direct competitors had integrated up and down the supply-chain. AVID had managed to forge strategic partnerships that allowed it to grow rapidly as an assembler of CPTs. Now that AVID was a significant industry player, however, the larger competitors were taking notice, and it was time to prepare a strategy that would continue AVID's growth.
Custom Procedure Tray (CPT) Business
. . .
Title: Avid Medical, Inc
Description:
This case describes the rapid growth of a start-up company which benefited from the identification of a specific market niche.
The company, over a short time, became positive in EBITDA and then PAT.
The case is rich in operational details regarding scheduling, inventories, workforce planning, capacity expansion, and customer service.
The strategic issue in the case involves the looming decision to carry the company through its next stage of expansion.
Excerpt
UVA-OM-1021
AVID Medical, INC.
Introduction
It was April 2002 and times were busy for Mike Sahady, the founder and Chief Executive Officer of AVID Medical, Inc.
(AVID Medical), and Rick Setian, the Chief Operating Officer.
Mike and Rick were busy devising a strategy for AVID Medical to continue into its next stage of growth.
AVID had grown from $ 8.
8M in revenue in FY2000 to $ 29.
5M in revenue for FY2002, and was the fifth largest provider of custom procedure trays (CPTs) in the United States.
CPTs were used to bundle all of the disposable supplies required for a single surgical procedure.
The CPT industry presented both challenges and opportunities for AVID.
AVID's suppliers and distributors were multi-billion dollar companies, and several of AVID's direct competitors had integrated up and down the supply-chain.
AVID had managed to forge strategic partnerships that allowed it to grow rapidly as an assembler of CPTs.
Now that AVID was a significant industry player, however, the larger competitors were taking notice, and it was time to prepare a strategy that would continue AVID's growth.
Custom Procedure Tray (CPT) Business
.
.
.
Related Results
OC-064 Pet Scanning in Gastric Cancer: a Comparison Of Avid Versus Non Avid Cancers
OC-064 Pet Scanning in Gastric Cancer: a Comparison Of Avid Versus Non Avid Cancers
Introduction
Only some gastric cancers (GC) are detectable on PET imaging (PET avid). Few studies have assessed the molecular and biological differences between P...
Prediction of 131I Uptake in Lung Metastases of Differentiated Thyroid Cancer Using Deep Learning
Prediction of 131I Uptake in Lung Metastases of Differentiated Thyroid Cancer Using Deep Learning
Abstract
Objective: An accurate assessment the 131I accumulation capacity in lung metastases of differentiated thyroid cancer (DTC) is pivotal to inform radioiodine therapy...
Characteristics, preferences and motivation of avid non-fiction readers
Characteristics, preferences and motivation of avid non-fiction readers
Purpose
This paper aims to provide insights into the characteristics of avid non-fiction book readers, exploring their typical demographic characteristics in rela...
Clarifying how hunt‐specific experiences affect satisfaction among more avid and less avid waterfowl hunters
Clarifying how hunt‐specific experiences affect satisfaction among more avid and less avid waterfowl hunters
ABSTRACT
Marketing research methods could enhance understanding of hunter satisfaction, a key metric for state wildlife management agencies. We used 3 marketing r...
Comparing meat abstainers with avid meat eaters and committed meat reducers
Comparing meat abstainers with avid meat eaters and committed meat reducers
Shifting our eating patterns toward less animal-based and more plant-based diets is urgently needed to counter climate change, address public health issues, and protect animal welf...
Coexistence of Lung Cancer and Warthin Tumour in a Smoker: Importance of Accurate Interpretation of 18F-FDG-Avid Parotid Lesions
Coexistence of Lung Cancer and Warthin Tumour in a Smoker: Importance of Accurate Interpretation of 18F-FDG-Avid Parotid Lesions
Warthin tumour is a benign salivary gland neoplasm strongly associated with smoking and known for avid 18F-FDG uptake. We report a 53-year-old male chronic smoker presenting with t...
Data from PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
Data from PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
<div>AbstractPurpose:<p>This work aimed to explore in depth the genomic and molecular underpinnings of hepatocellular carcinoma (HCC) with increased 2[18F]fluoro-2-deox...
Data from PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
Data from PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
<div>AbstractPurpose:<p>This work aimed to explore in depth the genomic and molecular underpinnings of hepatocellular carcinoma (HCC) with increased 2[18F]fluoro-2-deox...

